Abstract
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is a new treatment option in patients with peritoneal carcinomatosis (PC). PIPAC has proven efficacious in the treatment of PC from ovarian, colon and gastric cancer. PIPAC has a favourable profile regarding safety for patients and occupational health aspects. This study reviews the current evidence of PIPAC as a step towards implementation and evaluation in Denmark.
Original language | Danish |
---|---|
Article number | V11150928 |
Journal | Ugeskrift for Laeger |
Volume | 178 |
Issue number | 17 |
Pages (from-to) | 1606-1609 |
Number of pages | 2 |
ISSN | 0041-5782 |
Publication status | Published - 2016 |